Credentialing automation platform Baton Health launches Universal Primary Source database
That gives its customers access to hundreds of PSV databases through a single query
Read more...Shares of Facebook dropped 1.5% in after-hours trading, despite the company posting third-quarter results that beat Wall Street expectations on Tuesday.
Facebook shares had gone up .61% or $.049, to $80.77 a share in regular trading.
In the earnings report, Facebook posted revenue of $3.2 billion for the quarter, over Wall Street's estimates of $3.12 billion. Adjusted earnings per share came in at 43 cents in the quarter, higher than the 40 cents a share that analysts had been expecting.
So why did the stock take that dip, despite these good numbers? Because growth did slow in a few key areas.
Monthly active users (MAUs) were 1.35 billion on average, an increase of 14% year-over-year, while mobile MAUs were 1.12 billion on average, an increase of 29%. MAUs grew 2.27% quarter-to-quarter, lower than the 3.13% growth the company saw in Q2.
Advertising revenue was $2.96 billion for the quarter. It increased 59% from $2.02 billion in the same quarter the year before. Mobile accounted for 66% of that revenue, up from approximately 49% of advertising revenue in the third quarter of 2013. Facebook’s ad revenue had grown 67% percent year-to-year in Q2.
Revenue from payments and fees for the third quarter was $246 million, a 13% increase year-to-year.
GAAP net income was $806 million, a 90% increase from the $425 million the company saw for the third quarter of 2013, while non-GAAP net income for the quarter was $1..15 billion, up 73% compared to $666 million for the third quarter of 2013.
Daily active users (DAUs) were 846 million on average, an increase of 19% year-over-year, while mobile DAUs were 703 million on average, an increase of 39%.
For the year, the stock is up roughly 47%, rising from $54.83 to $80.77 . It has also gained 60% from a year ago, when it was trading at $50.23 a share.
(Image source: nbcnews.com)
That gives its customers access to hundreds of PSV databases through a single query
Read more...The company plans to bring its device to market in Europe before expanding to the United States
Read more...Talkspace will be the therapy partner for femtech brand Nurx and migraine treatment platform Cove
Read more...